期刊文献+

Mohnarin 2011年度报告:尿标本细菌耐药监测 被引量:73

Mohnarin report of 2011:monitoring of drug resistance of bacteria from urine specimens
原文传递
导出
摘要 目的了解我国尿路感染常见病原菌的分布及耐药性,为临床应用抗菌药物提供指导依据。方法对49所卫生部全国细菌耐药监测网(Mohnarin)成员单位分离自尿标本的细菌进行常规鉴定,采用纸片扩散法(K-B法)或自动化细菌鉴定系统测定细菌的耐药性,按CLSI 2010年版折点判断结果并采用WH0NET 5.6软件进行统计分析。结果共分离到细菌15 541株,其中革兰阳性菌4060株占26.1%,革兰阴性菌11 481株占73.9%,最常见细菌为大肠埃希菌7102株、屎肠球菌1337株、粪肠球菌1262株、肺炎克雷伯菌1142株、铜绿假单胞菌669株,分别占45.7%、8.6%、8.1%、7.3%、4.3%;大肠埃希菌和肺炎克雷伯菌ESBLs检出率分别为67.8%、64.9%,对碳青霉烯类抗菌药物最敏感,耐药率<3.0%,对阿米卡星、头孢哌酮/舒巴坦、哌拉西林/他唑巴坦耐药率均<20.0%;屎肠球菌对各种抗菌药物的耐药率明显高于粪肠球菌,耐万古霉素肠球菌检出率分别为3.3%、1.0%;耐甲氧西林金黄色葡萄球菌和耐甲氧西林凝固酶阴性葡萄球菌检出率分别为41.9%、77.7%,未检测到耐万古霉素菌株。结论我国尿路感染病原菌以大肠埃希菌为代表的革兰阴性杆菌为主,多药耐药菌株增加,细菌耐药性监测对及时了解病原菌及其耐药性非常重要。 OBJECTIVE To investigate the distribution and drug resistance of common pathogens causing urinary tract infections so as to provide basis for clnical use of antibiotics.METHODS All bacterial isolates from urine samples in 49 Mohnarin member hospitals were collected,antimicrobial susceptibility testing was carried out by K-B method or automatic microbiological analysis system,and the data were analyzed by Whonet 5.6 software according to CLSI 2010 breakpoints.RESULTS A total of 15 541 strains of clinical isolates were collected,consisting of 4060(26.1%) strains of gram-negative bacilli and 11 481(73.9%) strains of gram-positive cocci.The most common isolates were Escherichia coli(7102 strains,45.7%),Enterococcus faecium(1337 strains,8.6%),Enterococcus faecalis(1262 strains,8.1%),Klebsiellia pneumoniae(1142 strains,7.3%),and Pseudomonas aeruginosa(669 strains,4.3%).The prevalence of extended-spectrum β-lactamases(ESBLs) was 67.8% in E.coli,64.9% in K.pneumoniae.Imipenem and meropenem were the most potent antimicrobial agents against Enterobacteriaceae with the drug resistance rate less than 3.0%,the resistance rates to amikacin,cefoperazone-sulbactum and piperacillin-tazobactam were also less than 20.0%.E.faecium had higher resistance rates to almost all the antibiotics than did E.faecalis.The detection rates of the vancomycin-resistant E.faecalis and E.faecium were 3.3% and 1.0%.The detection rates of methicillin-resistant S.aureus(MRSA) and coagulase-negative Staphylococcus(MRCNS) were 41.9% and 77.7%,respectively.no vancomycin-resistant isolates were found.CONCLUSION The gram-negative bacilli such as E.coli are the predominant pathogens causing urinary tract infections in China,the multidrug-resistant pathogens have also increased,and it is very important for understanding the pathogens and the drug resistance to perform the monitoring of the bacterial resistance.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第24期5503-5507,共5页 Chinese Journal of Nosocomiology
基金 卫生行业科研专项项目(201002021)
关键词 卫生部全国细菌耐药监测网 尿路感染 病原菌 耐药性 Mohnarin Urinary tract infection Pathogen Drug resistance
  • 相关文献

参考文献6

  • 1Clinical and Laboratory Standards Institute.Performance standardsfor antimicrobial susceptibility testing:Fifteenth Information Sup-plement[M].M100-S20.CLSI,2010.
  • 2高磊,肖永红.Mohnarin 2008年度报告:男性尿标本细菌耐药监测研究[J].中国抗生素杂志,2010,35(8):633-638. 被引量:15
  • 3杨青,陈晓,孔海深,张伟丽,魏泽庆,沈萍,陈云波,肖永红,李兰娟.Mohnarin 2010年度报告:尿标本细菌耐药监测[J].中华医院感染学杂志,2012,22(3):476-480. 被引量:57
  • 4Chen S,Hu F,Xu X,et al.High prevalence of KPC-2-typecarbapenemase coupled with CTX-M-type extended-spectrumbeta-lactamases in carbapenem-resistant Klebsiella pneumoni-ae in a teaching hospital in China[J].Antimicrob Agents Che-mother,2011,55(5):2493-2494.
  • 5Jeffres MN,Shuster JE,Barclay SM.Treatment of ciproflox-acin nonsusceptible urinary tract infections with ciprofloxacin[J].Ann Pharmacother.2011,45(6):824-825.
  • 6Minardi D,d'Anzeo G,Cantoro D,et al.Urinary tract infec-tions in women:etiology and treatment options[J].Int J GenMed,2011,4:333-343.

二级参考文献24

  • 1王怡芳,龚晓红,朱云霞.女性尿路感染者病原学监测[J].中华医院感染学杂志,2005,15(2):223-225. 被引量:40
  • 2陈求刚,崔颖鹏,廖康,陈冬梅,曾燕,禤建美.泌尿系感染病原菌的分布及耐药性分析[J].中华医院感染学杂志,2006,16(5):579-581. 被引量:27
  • 3周蓉,张芸,沈菊英,沈杰,袁佳.尿路感染病原菌分布及抗菌药物耐药性[J].中华医院感染学杂志,2007,17(3):344-346. 被引量:41
  • 4马晓波,吕晓菊,过孝静,樊文星,康梅,简军,陈知行.5771份尿培养结果分析及药敏监测[J].四川大学学报(医学版),2007,38(4):745-747. 被引量:31
  • 5Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Fifteenth Information Sup- plement[S]. M100-S20. CLSI,2010.
  • 6Calbo E,Romani V,Xercavins M,et al. Risk factors for com- munity-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases[J]. J Antimi- crob Chemother, 2006,57 (4): 780-783.
  • 7Qi Y, Wei Z, Li L,et al. Detection of a common plasmid carry- ing blaKPC-2 in Enterobacteriaceae isolates from distinct cities in China[J]. Microb Drug Resist,2010,16(4):297-301.
  • 8Wei ZQ, Du XX, Yu YS,et al. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China [J]. Antimierob Agents Chemother, 2007,51(2) : 763-765.
  • 9Qi Y,Wei Z,Ji S,et al. STll, the dominant clone of KPC- producing Klebsiella pneumoniae in China[J]. J Antimicrob Chemother, 2011,66(2) : 307-312.
  • 10Jeffres MN, Shuster JE,Barclay SM. Treatment of ciprofloxa- cin nonsusceptible urinary tract infections with ciprofloxacin [J]. Ann Pharmacother,2011,45(6) :824-825.

共引文献69

同被引文献526

引证文献73

二级引证文献523

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部